Skip to main content

Roche Full Year Results 2025

Roche has published its Full Year Results for 2025 prior to the opening of the Swiss Stock Exchange on Thursday, 29 January 2026.

Agenda
OverviewThomas Schinecker, CEO Roche Group
Financial ResultsAlan Hippe, Chief Financial Officer
Pharmaceuticals DivisionTeresa Graham, CEO Roche Pharmaceuticals
Diagnostics DivisionMatt Sause, CEO Roche Diagnostics
Q&ABruno Eschli, Head of Investor Relations

Webinar Replay

Please click the video below to watch the replay of the webinar.

InvestorsPast IR Events
View more Events

Downloads

Download Annual Report

Download Annual Report 2025

English version

PDF

Download Financial Report

Discover more

  • Governance

    About Roche

    Our corporate governance principles focus on sustainable value creation and promote a culture that recognises standards of good corporate governance and a commitment to transparent communication.

  • Product Development Pipeline

    Solutions

    Discover our pipeline of Pharmaceutical and Diagnostics developments

  • Frequently asked questions

    Investors

    We answer the Roche investors-related most frequently asked questions

  • Finance Information Tool

    Investors

    Access the finance information tool for the latest Roche financial data.